These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 26351207)
1. Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway. Ji P; Yu L; Guo WC; Mei HJ; Wang XJ; Chen H; Fang S; Yang J Oncol Res; 2014; 22(4):185-191. PubMed ID: 26351207 [TBL] [Abstract][Full Text] [Related]
2. Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness. Zhang P; Yang Y; Nolo R; Zweidler-McKay PA; Hughes DP Oncogene; 2010 May; 29(20):2916-26. PubMed ID: 20208568 [TBL] [Abstract][Full Text] [Related]
3. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling. Li Y; Zhang J; Zhang L; Si M; Yin H; Li J Carcinogenesis; 2013 Jul; 34(7):1601-10. PubMed ID: 23430952 [TBL] [Abstract][Full Text] [Related]
4. Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling. Hu T; Fei Z; Su H; Xie R; Chen L Toxicol Appl Pharmacol; 2019 May; 371():55-62. PubMed ID: 30974157 [TBL] [Abstract][Full Text] [Related]
5. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors. Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051 [TBL] [Abstract][Full Text] [Related]
6. Cooperative functions of Hes/Hey genes in auditory hair cell and supporting cell development. Tateya T; Imayoshi I; Tateya I; Ito J; Kageyama R Dev Biol; 2011 Apr; 352(2):329-40. PubMed ID: 21300049 [TBL] [Abstract][Full Text] [Related]
7. A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro. Rathore K; Cekanova M Drug Des Devel Ther; 2015; 9():5323-35. PubMed ID: 26451087 [TBL] [Abstract][Full Text] [Related]
8. Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model. Barøy T; Kresse SH; Skårn M; Stabell M; Castro R; Lauvrak S; Llombart-Bosch A; Myklebost O; Meza-Zepeda LA Mol Cancer; 2014 Apr; 13():93. PubMed ID: 24885297 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway. Pan BL; Wu L; Pan L; Yang YX; Li HH; Dai YJ; He ZQ; Tan L; Huang YG; Tong ZW; Liao JL Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769415 [TBL] [Abstract][Full Text] [Related]
10. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer. So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438 [TBL] [Abstract][Full Text] [Related]
11. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines. Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102 [TBL] [Abstract][Full Text] [Related]
12. Critical role of notch signaling in osteosarcoma invasion and metastasis. Zhang P; Yang Y; Zweidler-McKay PA; Hughes DP Clin Cancer Res; 2008 May; 14(10):2962-9. PubMed ID: 18483362 [TBL] [Abstract][Full Text] [Related]
13. SiRNA-mediated silencing of beta-catenin suppresses invasion and chemosensitivity to doxorubicin in MG-63 osteosarcoma cells. Zhang F; Chen A; Chen J; Yu T; Guo F Asian Pac J Cancer Prev; 2011; 12(1):239-45. PubMed ID: 21517265 [TBL] [Abstract][Full Text] [Related]
14. Expression of the Notch signaling pathway and effect on exocrine cell proliferation in adult rat pancreas. Rooman I; De Medts N; Baeyens L; Lardon J; De Breuck S; Heimberg H; Bouwens L Am J Pathol; 2006 Oct; 169(4):1206-14. PubMed ID: 17003479 [TBL] [Abstract][Full Text] [Related]
15. TFAP2C-mediated LINC00922 signaling underpins doxorubicin-resistant osteosarcoma. Gu Z; Zhou Y; Cao C; Wang X; Wu L; Ye Z Biomed Pharmacother; 2020 Sep; 129():110363. PubMed ID: 32563982 [TBL] [Abstract][Full Text] [Related]
16. Hes1/Hes5 gene inhibits differentiation via down-regulating Hash1 and promotes proliferation in cervical carcinoma cells. Liu J; Lu WG; Ye F; Cheng XD; Hong D; Hu Y; Chen HZ; Xie X Int J Gynecol Cancer; 2010 Oct; 20(7):1109-16. PubMed ID: 21495212 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis. Zhou B; Li L; Li Y; Sun H; Zeng C Biomed Pharmacother; 2018 Oct; 106():850-857. PubMed ID: 30119255 [TBL] [Abstract][Full Text] [Related]
18. Curcumin attenuates endothelial cell oxidative stress injury through Notch signaling inhibition. Yang Y; Duan W; Liang Z; Yi W; Yan J; Wang N; Li Y; Chen W; Yu S; Jin Z; Yi D Cell Signal; 2013 Mar; 25(3):615-29. PubMed ID: 23219912 [TBL] [Abstract][Full Text] [Related]
19. Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells. Kunnimalaiyaan S; Trevino J; Tsai S; Gamblin TC; Kunnimalaiyaan M Mol Cancer Ther; 2015 Jun; 14(6):1395-403. PubMed ID: 25887885 [TBL] [Abstract][Full Text] [Related]